Reply to Musher.

Brousseau, Nicholas; Slack, Mary P E; Waight, Pauline; Borrow, Ray; Ladhani, Shamez N

Reply to Musher.

Brousseau, Nicholas; Slack, Mary P E; Waight, Pauline; Borrow, Ray; Ladhani, Shamez N.

Afiliação

Brousseau N; Department of Immunisation, Hepatitis and Blood Safety, Public Health England, London, United Kingdom Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale, Québec, Canada.
Slack MP; Department of Medicine, Griffith University, Southport, Queensland, Australia Institute of Hygiene and Microbiology, University of Würzburg, Germany.
Waight P; Department of Immunisation, Hepatitis and Blood Safety, Public Health England, London, United Kingdom.
Borrow R; Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom.
Ladhani SN; Department of Immunisation, Hepatitis and Blood Safety, Public Health England, London, United Kingdom.

Clin Infect Dis ; 62(1): 133-4, 2016 Jan 01.

Article em En | MEDLINE | ID: mdl-26371153

Assuntos

Anticorpos Antibacterianos/sangue; Vacina Pneumocócica Conjugada Heptavalente/imunologia; Infecções Pneumocócicas/imunologia; Infecções Pneumocócicas/microbiologia; Streptococcus pneumoniae/imunologia; Feminino; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Streptococcus pneumoniae / Vacina Pneumocócica Conjugada Heptavalente / Anticorpos Antibacterianos Limite: Female / Humans / Male Idioma: En Revista: Clin Infect Dis Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google